Results 221 to 230 of about 1,867,784 (281)

CEACAM1 participation in breast cancer progression

open access: yesMolecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin   +3 more
wiley   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

open access: yesMolecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas   +16 more
wiley   +1 more source

Fragile research systems, brain drain, and predatory publishing in under-resourced countries. [PDF]

open access: yesMicrolife
Jonjić S   +7 more
europepmc   +1 more source

Scaling biodiversity conservation through institutional reform. [PDF]

open access: yesConserv Biol
Zhang L   +10 more
europepmc   +1 more source

Spectrofluorimetric Method for Sensitive Histamine Detection Using Europium Complexation. [PDF]

open access: yesACS Omega
Kamel KB   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy